Department of Ophthalmology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
Department of Ophthalmology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea
Br J Ophthalmol. 2019 Feb;103(2):269-273. doi: 10.1136/bjophthalmol-2017-311704. Epub 2018 Apr 29.
To evaluate the clinical characteristics and treatment outcomes of natural killer/T-cell lymphoma (NKTL) involving the ocular adnexa.
Retrospective, comparative, observational case series. A total of 350 patients with NKTL, including 27 patients with NKTL involving the ocular adnexa from 1999 to 2016. The patients were grouped into two groups: group 1 comprised patients presenting with ophthalmic symptoms, and group 2 comprised patients presenting with symptoms from other organs but subsequently developed ophthalmic involvement.
Group 1 comprised 12 patients (44.4%) and group 2 comprised 15 (55.6%). Mean duration of symptoms in group 1 was 1.8±1.2 months, while the time from diagnosis of NKTL to development of ophthalmic symptoms in group 2 was 45.3±65.6 months. Periorbital swelling was the most common presenting symptom in both groups (83.3% in group 1 and 73.3% in group 2). Symptoms mimicking cellulitis and pseudotumor were present in 50.0% and 16.7% of cases, respectively. The 5-year overall survival rate was 18.5% in group 1 and 26.4% in group 2, while the 5-year progression-free survival rate was 0% and 13.3%, respectively.
Our series is to our knowledge the largest cohort study on NKTL reported to date and demonstrates that ocular adnexal NKTL is a rare but seriously fatal disease. It is characterised by acute inflammatory signs as present in as many as two-thirds of our patients in this series. It should be considered as a differential diagnosis in patients presenting with rapidly progressing proptosis and diagnosed promptly for optimal management.
评估涉及眼附属器的自然杀伤细胞/ T 细胞淋巴瘤(NKTL)的临床特征和治疗结果。
回顾性、对比、观察性病例系列研究。共纳入 350 例 NKTL 患者,其中 27 例 NKTL 累及眼附属器,这些患者来自 1999 年至 2016 年。将患者分为两组:第 1 组包括以眼部症状就诊的患者,第 2 组包括以其他器官症状就诊但随后出现眼部受累的患者。
第 1 组包括 12 例患者(44.4%),第 2 组包括 15 例患者(55.6%)。第 1 组的症状持续时间平均为 1.8±1.2 个月,而第 2 组从 NKTL 诊断到出现眼部症状的时间为 45.3±65.6 个月。眶周肿胀是两组中最常见的首发症状(第 1 组为 83.3%,第 2 组为 73.3%)。分别有 50.0%和 16.7%的病例出现类似蜂窝织炎和假性肿瘤的症状。第 1 组的 5 年总生存率为 18.5%,第 2 组为 26.4%,第 1 组的 5 年无进展生存率为 0%,第 2 组为 13.3%。
本研究是迄今为止关于 NKTL 的最大队列研究,表明眼附属器 NKTL 是一种罕见但严重致命的疾病。其特征是急性炎症表现,在本研究的多达三分之二的患者中存在这种表现。在出现快速进展性眼球突出的患者中,应将其视为鉴别诊断,并及时诊断以获得最佳治疗效果。